{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:15:07Z","timestamp":1759335307660},"reference-count":14,"publisher":"Cambridge University Press (CUP)","issue":"11","license":[{"start":{"date-parts":[[2016,6,21]],"date-time":"2016-06-21T00:00:00Z","timestamp":1466467200000},"content-version":"unspecified","delay-in-days":3520,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infect. Control Hosp. Epidemiol."],"published-print":{"date-parts":[[2006,11]]},"abstract":"<jats:sec id=\"S0899823X00196801_abs1\"><jats:title>Objective.<\/jats:title><jats:p>To assess the optimal method for covering smallpox vaccination sites to prevent transmission of vaccinia.<\/jats:p><\/jats:sec><jats:sec id=\"S0899823X00196801_abs2\"><jats:title>Design.<\/jats:title><jats:p>Randomized, nonblinded clinical trial.<\/jats:p><\/jats:sec><jats:sec id=\"S0899823X00196801_abs3\"><jats:title>Setting.<\/jats:title><jats:p>Tertiary care medical center.<\/jats:p><\/jats:sec><jats:sec id=\"S0899823X00196801_abs4\"><jats:title>Participants.<\/jats:title><jats:p>Vaccinia-naive and vaccinia-experienced volunteers.<\/jats:p><\/jats:sec><jats:sec id=\"S0899823X00196801_abs5\"><jats:title>Interventions.<\/jats:title><jats:p>After vaccination, study participants were randomized to receive 1 of 3 types of bandage: gauze, occlusive with gauze lining, or foam. Vaccination sites were assessed every 3 to 5 days until the lesion healed. During each visit, specimens were obtained from the vaccination site, the bandage surface before removal, and the index finger contralateral to the vaccination site and were cultured for vaccinia. Time to lesion healing was assessed.<\/jats:p><\/jats:sec><jats:sec id=\"S0899823X00196801_abs6\"><jats:title>Results.<\/jats:title><jats:p>All 48 vaccinia-naive and 47 (87%) of 54 vaccinia-experienced participants developed a vesicle or pustule at the injection site 6-11 days after vaccination. Fourteen (14%) of 102 participants had bandage cultures positive for vaccinia. All but 1 of these vaccinia-positive cultures were of a bandage from participants randomized to the gauze bandage group, and all but 3 were of bandages from vaccinia-naive participants. No finger-specimen cultures were positive for vaccinia. One episode of neck autoinoculation occurred in a vaccinia-naive individual who had vaccinia recovered from his gauze bandage on multiple visits. The foam bandage was associated with more local adverse effects (skin irritation and induration). The time to healing did not differ among the bandage groups.<\/jats:p><\/jats:sec><jats:sec id=\"S0899823X00196801_abs7\"><jats:title>Conclusions.<\/jats:title><jats:p>The potential for transmission of vaccinia from a vaccination site is greater if the site is covered by gauze than if it is covered by occlusive or foam bandages. Use of an occlusive bandage with a gauze lining is the best choice for coverage of smallpox vaccination sites because of a reduced potential for vaccinia transmission and a lower reactogenicity rate. Bandage choice did not affect vaccination lesion healing.<\/jats:p><\/jats:sec>","DOI":"10.1086\/508827","type":"journal-article","created":{"date-parts":[[2006,10,25]],"date-time":"2006-10-25T16:44:35Z","timestamp":1161794675000},"page":"1184-1192","source":"Crossref","is-referenced-by-count":10,"title":["Optimal Bandaging of Smallpox Vaccination Sites to Decrease the Potential for Secondary Vaccinia Transmission Without Impairing Lesion Healing"],"prefix":"10.1017","volume":"27","author":[{"given":"Thomas R.","family":"Talbot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jody","family":"Peters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter F.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn M.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2016,6,21]]},"reference":[{"key":"S0899823X00196801_ref006","first-page":"1","article-title":"Smallpox vaccination and adverse reactions: guidance for clinicians","volume":"52","author":"Cono","year":"2003","journal-title":"MMWR Recomm Rep"},{"key":"S0899823X00196801_ref009","unstructured":"National Cholesterol Education Program. Risk assessment tool for estimating your 10-year risk of having a heart attack. Available at http:\/\/hm.nhlbi.nih.gov\/atpiii\/calculator.asp?usertype=pub. Accessed July 5, 2004."},{"key":"S0899823X00196801_ref002","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra022500"},{"key":"S0899823X00196801_ref008","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.10.1205"},{"key":"S0899823X00196801_ref003","unstructured":"Centers for Disease Control and Prevention. Smallpox vaccine: vaccination site care and precautions for recipients. Available at http:\/\/www.bt.cdc.gov\/agent\/smallpox\/vaccination\/vaccination-program-qa.asp?tvpe=cat&cat=Smallpox+Vaccine&subCat =Vaccination+Site+Care+and+Precautions+for+Recipients. Accessed November 17, 2005."},{"key":"S0899823X00196801_ref005","doi-asserted-by":"publisher","DOI":"10.1086\/377236"},{"key":"S0899823X00196801_ref012","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2003.08.006"},{"key":"S0899823X00196801_ref010","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.22.2127"},{"key":"S0899823X00196801_ref014","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2004.03.007"},{"key":"S0899823X00196801_ref007","doi-asserted-by":"publisher","DOI":"10.1086\/423967"},{"key":"S0899823X00196801_ref011","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/166.2.244"},{"key":"S0899823X00196801_ref013","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)91636-9"},{"key":"S0899823X00196801_ref004","doi-asserted-by":"publisher","DOI":"10.1086\/381205"},{"key":"S0899823X00196801_ref001","first-page":"1","article-title":"Recommendations for using smallpox vaccine in a pre-event vaccination program: supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC)","volume":"52","author":"Wharton","year":"2003","journal-title":"MMWR Recomm Rep"}],"container-title":["Infection Control &amp; Hospital Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0899823X00196801","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T06:20:02Z","timestamp":1614061202000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0899823X00196801\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":14,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S0899823X00196801"],"URL":"https:\/\/doi.org\/10.1086\/508827","relation":{},"ISSN":["0899-823X","1559-6834"],"issn-type":[{"value":"0899-823X","type":"print"},{"value":"1559-6834","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}